Pharma Companies Extend Patent Life With Slight Modifications
Introduction The pharmaceutical industry is one of the most potential industry which has huge profit margins. Extensive growth and knowledge are required with frequent changes for better technology and results. Starting from early to the final stage there are gigantic chances of the product’s to face success or failure. Apart from these challenges, a large […]
Unboxing The Confusion In Marks Of Pharmaceutical Products
It is not new that the Supreme Court had cautiously laid down the seven principles for determining confusion or deceptiveness in pharmaceutical products. The landmark case of Cadilla held that medicines are boon but if given wrongly it can have life-threatening impact. Thus, there need not be an iota of confusion in the mind of […]
Successful Completion of International Patent Drafting Competition 2017
IIPRD, along with Khurana & Khurana, Advocates and IP Attorneys (K&K) and its eminent foreign associates, conducted Third edition of International Patent Drafting Competition (IPDC). IPDC was designed with an objective to test acumen and skill set of various practitioners pertaining to patent drafting that forms a critical part in patent lifecycle. IPDC aims to encourage people […]
Injunction against Cipla COPD Drug ‘INDAFLO’ Upheld: Delhi High Court
Reportedly, on an appeal filed by Cipla pertaining to COPD drug INDAFLO, the Delhi High court division bench maintained the interim injunction imposed by single judge against Cipla. As per the order, Cipla has now been restrained from, inter alia, using, manufacturing, importing, selling any pharmaceutical products etc. containing ‘INDACATEROL‘ or ‘INDACATEROL Maleate‘, alone or […]
Injunction against Cipla COPD Drug ‘INDAFLO’ Upheld: Delhi High Court
Reportedly, on an appeal filed by Cipla pertaining to COPD drug INDAFLO, the Delhi High court division bench maintained the interim injunction imposed by single judge against Cipla. As per the order, Cipla has now been restrained from, inter alia, using, manufacturing, importing, selling any pharmaceutical products etc. containing ‘INDACATEROL‘ or ‘INDACATEROL Maleate‘, alone or […]
Analysis of the rejection of Lumacaftor (Polymorph) patent application in India
We have been receiving requests from our Pharma clients/readers of the blog for the analysis of the decision/ facts that led to rejection of Lumacaftor (Polymorph) patent application in India since last year. Here is our take: Details of the Patent Application and important dates: Patent application number in India 2056/KOLNP/2010 Title of the invention […]
Analysis of the rejection of Lumacaftor (Polymorph) patent application in India
We have been receiving requests from our Pharma clients/readers of the blog for the analysis of the decision/ facts that led to rejection of Lumacaftor (Polymorph) patent application in India since last year. Here is our take: Details of the Patent Application and important dates: Patent application number in India 2056/KOLNP/2010 Title of the invention […]
U.S. District Court Confirms Validity of Patent For UCB Pharma’s Vimpat®
UCB Pharma, a Belgian pharmaceutical company, announced on 14th August 2016 that the U.S. District Court for the District of Delaware confirmed the validity of its U.S. reissued patent RE38551 related to anti-epileptic drug Vimpat® (lacosamide). The patent challenge was brought by generic drug makers who had questioned the validity of the UCB’s patent which […]
India’s First IP Crime Unit Launched in Telangana State
Piracy is one of the major evil Indian IP industry is facing for decades and the same is growing day by day rooting into the system causing irreparable loss to the economic reputation of the country. As per the report by Ernst & Young, Indian films industry has sustained loss of around USD 959 (Rs. […]
IP Workshop held at Hotel Hilton, Jaipur
IIPRD in association with Khurana and Khurana, Advocates and IP attorneys has recently conducted an IP Workshop on 8th of February, 2016 at “Hotel Hilton”, Jaipur. Hereinbelow are the snapshots of activities conducted at the workshop – As a part of our ongoing Educational and Awareness Programme on IPR, IIPRD takes pride to have successfully […]